2008
Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users
Hu Y, Grau LE, Scott G, Seal KH, Marshall PA, Singer M, Heimer R. Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users. American Journal Of Preventive Medicine 2008, 35: 25-32. PMID: 18541174, PMCID: PMC2483306, DOI: 10.1016/j.amepre.2008.03.028.Peer-Reviewed Original ResearchConceptsInjection drug usersSyringe exchange programsHBV vaccinationDrug usersHepatitis B vaccination coverageActive injection drug usersAcute HBV infectionHepatitis B infectionHepatitis B vaccineQuality-adjusted life yearsAbsence of vaccinationLocal health departmentsDifferent vaccination strategiesVaccination program costsB infectionHBV infectionB vaccineFirst doseVaccination scheduleVaccination coverageVaccination strategiesCost-saving strategyVaccination campaignHigh riskMedical costs
1999
Survival of HIV-1 in Syringes
Abdala N, Stephens C, Griffith B, Heimer R. Survival of HIV-1 in Syringes. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 20: 73-80. PMID: 9928733, DOI: 10.1097/00042560-199901010-00011.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeHIV-1HumansReproducibility of ResultsSensitivity and SpecificitySubstance Abuse, IntravenousSyringes